Ok Biotech Co Ltd - Asset Resilience Ratio
Ok Biotech Co Ltd (4155) has an Asset Resilience Ratio of 0.32% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Ok Biotech Co Ltd (4155) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2024)
This chart shows how Ok Biotech Co Ltd's Asset Resilience Ratio has changed over time. See 4155 total equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Ok Biotech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Ok Biotech Co Ltd market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$12.36 Million | 0.32% |
| Total Liquid Assets | NT$12.36 Million | 0.32% |
Asset Resilience Insights
- Limited Liquidity: Ok Biotech Co Ltd maintains only 0.32% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Ok Biotech Co Ltd Industry Peers by Asset Resilience Ratio
Compare Ok Biotech Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Beijing Wandong Medical Technology Co Ltd
SHG:600055 |
Medical Devices | 4.92% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
MODULIGHT OY EO 1
F:78W |
Medical Devices | 22.31% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.39% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Nova EYE Medical Ltd
AU:EYE |
Medical Devices | 11.08% |
Annual Asset Resilience Ratio for Ok Biotech Co Ltd (2021–2024)
The table below shows the annual Asset Resilience Ratio data for Ok Biotech Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.35% | NT$13.04 Million ≈ $410.89K |
NT$3.70 Billion ≈ $116.42 Million |
-1.03pp |
| 2023-12-31 | 1.38% | NT$42.31 Million ≈ $1.33 Million |
NT$3.07 Billion ≈ $96.64 Million |
+0.07pp |
| 2022-12-31 | 1.31% | NT$40.23 Million ≈ $1.27 Million |
NT$3.06 Billion ≈ $96.44 Million |
-0.28pp |
| 2021-12-31 | 1.59% | NT$44.78 Million ≈ $1.41 Million |
NT$2.81 Billion ≈ $88.62 Million |
-- |
About Ok Biotech Co Ltd
OK Biotech Co., Ltd. develops, manufactures, markets, and sells blood glucose monitoring systems and homecare healthcare devices in Taiwan and internationally. It also offers OTC hearing aids, multi-frequency therapy devices, and factory setup solutions. The company was founded in 2004 and is based in Hsinchu City, Taiwan.